Emails indicate that the manager disappeared during questioning. Late last week, advocates continued to question one of the prosecution's key witnesses, in an effort to make Dr. Adam Rosendorff unreliable.
Three facts could hurt Rosendorf in the eyes of the jury. Whether these facts diminish his previous testimony depends largely on Holmes' defence. This will be difficult given the shocking facts presented by Rosendorf during the prosecutor's cross-examination. But the credibility of key witnesses is something all defenses should strive for.
Initially, R&Ndorf, while questioning Holmes' attorney Lance Wade, admitted that he had controversially confirmed the company. The Quarterly Policy Perths while Tranos has no official policy on how to eliminate outcasts - despite numerous guidelines for doing so - the company has developed a framework called the Six Point Policy. Each sample gave six results, two were discarded and the remaining four samples were averaged. The policy says removing two items is a good thing, but it hasn't helped lab technicians determine the best candidates for removal. So it's a policy, but it doesn't cover everything.
READ MORE Teranos fails pharmaceutical evaluation, while laboratory director clears him for seven second tests, Rosendorf appears to have a stronger hand in developing and implementing laboratory protocols than his previous certification. For the first time, he signed an "alternative evaluation method" for Theranos' Edison hardware, which is essentially a set of aptitude tests that differ from the tests used to validate other diagnostic equipment. He acknowledged that Erica Chung's lab technique did not use an alternative method to Risendorf because he was concerned about Edison's lack of quality control oversight. Risendorf also worked with Ramesh "Sunny" Palwani, president of Theranos and COO, to edit a slide page designed to teach lab techniques on the company's unique specialized testing method. "Tranos experiences have no peer," one slide says. Balvani and other executives were invited to express their concerns about Tranos' testing methods, and R & Sndorf admitted under SWLWide that there are no restrictions on what he can say at the meeting. Friday's testimony reinforces his earlier statements.
Initially, Blovani emailed Theranos' Vice Chairman of the Board of Directors in June 2014, a few months before Reisendorff resigned. “I am very upset that he was not informed as a manager from the laboratory.” Rosendorf told prosecutors they would confirm - he was out of the loop - in a series of new emails we found out that R&D Zendorf had been slow to follow up on complaints from Dr. In two separate cases, the lab manager took more than a week to follow up with the doctor about suspicious test results.
Read more A jury can explain this in several ways. The jury might find Rezandorf untrustworthy, which is probably what Wade wants. But they can also be more sympathetic - however, Rezundorf seems to have dealt with complaints more than the typical lab. In addition, he was constantly involved with the managers on how to run the lab. Given these fires, it's easy to see why "Respond to Customer Complaints" was omitted from the list.
A week to address a complaint may not be normal in a clinical lab, but Tranus clearly didn't run a normal lab.
Index of images by Jane Tesca / First Digital Media / Mercury News
The court says the director of the Tranos lab signed the policy on the basis of suspicious information
Four days ago, the ransomware website REvil, better known as "...
There is a saying in the startup world that many companies are trying to sh...
Last month, Intel CEO Pat Gelsinger took to the podium on a foggy and win...